Philip Harvey

1 presentation

• T105. ACTIVE AND PASSIVE DIGITAL PHENOTYPING TO MEASURE OUTCOMES IN A 12-MONTH STUDY OF XANOMELINE/ TROSPIUM CHLORIDE IN SCHIZOPHRENIA: LONGITUDINAL PREDICTION OF TOTAL CHANGES WITH EARLY LEVELS OF PHYSICAL ACTIVITY

  2026 ASCP Annual Meeting